The CEO of infant formula maker Bubs Australia says that the market dynamics in the US has given the firm the confidence that it will become as significant as China.
China’s indefinite suspension of all its activities under its Strategic Economic Dialogue with Australia is unlikely to affect the supplements industry, due to consumers’ preference for Australia-made products and the fact that a number of brands with...
Belgium start-up MY Health, which specialises in spore-forming probiotics (sporebiotics), is expanding into Asia, with India and greater China in the plans for products that tackle the side-effects of proton pump inhibitor medications.
New Zealand's domestic organic product sector is growing twice as fast as its non-organic sector, up 8.1% per year in retail sales versus the latter's 4.8%.